Tata likely to launch Moderna vaccine in India, says report

The company could team up with the Council of Scientific & Industrial Research to carry out clinical trials of the vaccine candidate in India

January 26, 2021 02:21 am | Updated January 31, 2021 05:08 pm IST

Tata Medical & Diagnostics is said to have started initial discussions with Moderna Inc. for a partnership to launch its COVID-19 vaccine in India, the Economic Times reported on Monday.

Tata could team up with the Council of Scientific & Industrial Research (CSIR) to carry out clinical trials of Moderna’s vaccine candidate in India, the report added, citing officials familiar with the matter.

The Central government this month gave emergency-use approval to a COVID-19 vaccine developed by Bharat Biotech International Ltd. and the Indian Council of Medical Research; another vaccine licensed from Oxford University and AstraZeneca PLC that is being manufactured by the Serum Institute of India was approved.

Moderna and Tata Medical & Diagnostics did not respond to Reuters’ request for a comment.

 

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.